Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from Tanzania
- PMID: 1619399
- DOI: 10.1002/jmv.1890370111
Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from Tanzania
Abstract
A total of 160 sera from HIV-1 infected individuals from Tanzania were examined for their fine specificity characteristics relative to 9 synthetic peptides that define HIV-1 gp160 epitopes. Immunorecessive and immunodominant epitopes were identified in both gp120 and gp41 based on serologic reactivity of these HIV-1 infected sera. A significant difference in fine specificity among HIV-1 infected individuals from Tanzania and the United States was observed for an immunodominant gp41 epitope. No significant differences in reactivity among asymptomatic vs. symptomatic HIV-1 infected individuals were detected for the selected HIV-1 gp160 epitopes defined by these peptides. The majority of sera from HIV-1 infected Tanzanians contained antibodies that recognized a peptide corresponding to the V3 region of gp120 from the HIV-1 MN isolate. These data suggest that regional isolates of HIV-1 may exist in Tanzania that differ from HIV-1 isolated in the United States. However, based on serology, HIV-1 isolates exhibiting sequences with HIV-1 MN V3 similarity may also be prevalent in Tanzania. The results of this study may be useful for the design of more effective AIDS diagnostic and therapeutic products for use worldwide.
Similar articles
-
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.J Clin Microbiol. 1992 Jan;30(1):126-31. doi: 10.1128/jcm.30.1.126-131.1992. J Clin Microbiol. 1992. PMID: 1370844 Free PMC article.
-
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002. AIDS. 1993. PMID: 8363754
-
Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):995-1005. doi: 10.1089/aid.1997.13.995. AIDS Res Hum Retroviruses. 1997. PMID: 9264286
-
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.Int Rev Immunol. 1992;8(1):65-81. doi: 10.3109/08830189209056642. Int Rev Immunol. 1992. PMID: 1374113 Review.
-
Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.Immunol Lett. 1997 Jun 1;57(1-3):105-12. doi: 10.1016/s0165-2478(97)00043-6. Immunol Lett. 1997. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0 PMID: 9232434 Corrected and republished. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical